Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells

Cancer statistics, 2011

Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Identification of the breast cancer susceptibility gene BRCA2

Richard Wooster, Graham R. Bignell, Jonathan Lancaster et al. · Nature · 1995 · 3.7K citations

Medicine, Genetics, Molecular Genetics +9

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

Jeff Hall, Ming K. Lee, Beth Newman et al. · Science · 1990 · 2.5K citations

Life Sciences, Genetics, Molecular Genetics +14

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Sunil R. Lakhani, Marc J. van de Vijver, Jocelyne Jacquemier et al. · Journal of Clinical Oncology · 2002 · 827 citations

Medicine, Oncology, Pathology +17

Pathologic Complete Response Rates in Young Women With <i>BRCA1</i>-Positive Breast Cancers After Neoadjuvant Chemotherapy

Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski et al. · Journal of Clinical Oncology · 2009 · 507 citations · Full text

Medicine, Oncology, Pharmacology +14